A Gelatin Methacrylate-Based Hydrogel as a Potential Bioink for 3D Bioprinting and Neuronal Differentiation
Pharmaceutics · 13.02.2023 · 15 (2) · 627
DOI: 10.3390/pharmaceutics15020627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 13.02.2023. Verfasst von Elisa Marozzi Cruz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Neuronal loss is the ultimate pathophysiologic event in central nervous system (CNS) diseases and replacing these neurons is one of the most significant challenges in regenerative medicine. Providing a suitable microenvironment for new neuron engraftment, proliferation, and synapse formation is a primary goal for 3D bioprinting. Among the various biomaterials, gelatin methacrylate (GelMA) stands out due to its Arg-Gly-Asp (RGD) domains, which assure its biocompatibility and degradation under physiological conditions. This work aimed to produce different GelMA-based bioink compositions, verify their mechanical and biological properties, and evaluate their ability to support neurogenesis. We evaluated four different GelMA-based bioink compositions; however, when it came to their biological properties, incorporating extracellular matrix components, such as GeltrexTM, was essential to ensure human neuroprogenitor cell viability. Finally, GeltrexTM: 8% GelMA (1:1) bioink efficiently maintained human neuroprogenitor cell stemness and supported neuronal differentiation. Interestingly, this bioink composition provides a suitable environment for murine astrocytes to de-differentiate into neural stem cells and give rise to MAP2-positive cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil.
- Department of Materials Engineering, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil.
ORCID-Profile: Lucas Simões Machado, Laura Nicoleti Zamproni, Larissa Valdemarin Bim, Eduardo Henrique Backes, Marimélia Aparecida Porcionatto
Förderung
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Zitieren
APA
Cruz, E. M., Machado, L. S., Zamproni, L. N., Bim, L. V., Ferreira, P. S., Pinto, L. A., Pessan, L. A., Backes, E. H., & Porcionatto, M. A. (2023). A Gelatin Methacrylate-Based Hydrogel as a Potential Bioink for 3D Bioprinting and Neuronal Differentiation. Pharmaceutics, 15(2), 627. https://doi.org/10.3390/pharmaceutics15020627
Vancouver
Cruz EM, Machado LS, Zamproni LN, Bim LV, Ferreira PS, Pinto LA, et al. A Gelatin Methacrylate-Based Hydrogel as a Potential Bioink for 3D Bioprinting and Neuronal Differentiation. Pharmaceutics. 2023;15(2):627. doi:10.3390/pharmaceutics15020627
BibTeX
@article{Cruz2023,
author = {Cruz, Elisa Marozzi and Machado, Lucas Simões and Zamproni, Laura Nicoleti and Bim, Larissa Valdemarin and Ferreira, Paula Scanavez and Pinto, Leonardo Alves and Pessan, Luiz Antonio and Backes, Eduardo Henrique and Porcionatto, Marimélia Aparecida},
title = {A Gelatin Methacrylate-Based Hydrogel as a Potential Bioink for 3D Bioprinting and Neuronal Differentiation},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {627},
doi = {10.3390/pharmaceutics15020627}
}
EUVIMED